Average Co-Inventor Count = 4.83
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bayer Corporation (13 from 1,008 patents)
2. Cgi Pharmaceuticals, Inc. (3 from 13 patents)
3. Bayer Pharmaceuticals Corporation (2 from 70 patents)
4. Other (1 from 832,843 patents)
5. Genentech, Inc. (1 from 3,222 patents)
6. Gilead Connecticut, Inc. (1 from 30 patents)
20 patents:
1. 8426424 - Certain substituted amides, method of making, and method of use thereof
2. 8222421 - Certain substituted ureas, as modulators of kinase activity
3. 7947835 - Certain substituted amides, method of making, and method of use thereof
4. 7777040 - Certain substituted ureas, as modulators of kinase activity
5. 6911449 - Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids
6. 6762184 - Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids
7. 6541468 - Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer
8. 6500847 - Inhibition of matrix metalloproteases by substitued biaryl oxobutyric acids
9. 6353006 - Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
10. 6288063 - Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors
11. 6225314 - Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids
12. 6166082 - Substituted 5-biarylpentanoic acids and derivatives as matrix
13. 6013646 - Indolocarbazole derivatives useful for the treatment of
14. 5932577 - Substituted oxobutyric acids as matrix metalloprotease inhibitors
15. 5925637 - Inhibition of matrix metalloproteases by substituted biaryl oxobutyric